PAREXEL International Corporation : Technical rebound expected
Entry price | Target | Stop-loss | Potential |
---|
$58.56 |
$0 |
$56.4 |
-100% |
---|
PAREXEL International Corporation shows relatively strong fundamentals and is coming back to attractive prices.
In the recent months, the earnings estimates for the next year have been regularly revised upward by analysts.
With an EPS estimated at USD 3.08 for this year and USD 3.94 for the next year, PAREXEL International Corporation is currently paid 19.02 and 14.86 times the results.
Technically, the security fell sharply for several weeks. This fall has lead PAREXEL International Corporation towards the USD 57.45 support area, which could become useful as a stepping stone for a technical rebound.
The target of this bullish trend is the USD 61.95 resistance. Even though moving averages are still in a bearish trend, the oversold situation could encourage a renewed interest in PAREXEL International Corporation.
In consequence, investors could buy the stock in the current area with the USD 61.95 resistance as a first target. The Stop-loss will be triggered below the support currently tested.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.